Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development

Kelly E Courtney; Lara A Ray

doi:10.1016/bs.pbr.2015.07.010

Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development

Prog Brain Res. 2016:223:295-310. doi: 10.1016/bs.pbr.2015.07.010. Epub 2015 Oct 16.

Authors

Kelly E Courtney¹, Lara A Ray²

Affiliations

¹ Department of Psychology, University of California, Los Angeles, CA, USA.
² Department of Psychology, University of California, Los Angeles, CA, USA. Electronic address: lararay@psych.ucla.edu.

PMID: 26806782
DOI: 10.1016/bs.pbr.2015.07.010

Abstract

Abuse of amphetamine-type stimulants (ATS) poses a significant public health concern with known neurotoxic and neurocognitive effects to the user. In this chapter, we seek to integrate the latest research on ATS, particularly methamphetamine, by covering areas of pharmacology, neurocognitive effects, and the treatment of ATS use disorders with the goal of advancing the clinical neuroscience of ATS and highlighting avenues for future research.

Keywords: ATS use disorders; Addiction; Amphetamine; Clinical neuroscience; Methamphetamine; Stimulants; Treatment.

Publication types

Review

MeSH terms

Amphetamine / pharmacology*
Amphetamine-Related Disorders / drug therapy*
Amphetamine-Related Disorders / physiopathology
Animals
Central Nervous System Stimulants / pharmacology*
Humans
Neurosciences
Neurotoxicity Syndromes / drug therapy*
Neurotoxicity Syndromes / physiopathology
Research*

Substances

Central Nervous System Stimulants
Amphetamine